Is a complete TENX research report available?

No complete published report is available for Tenax Therapeutics, Inc. (TENX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Tenax Therapeutics, Inc. (TENX)

NASDAQ: TENX · USD

$15.1

+0.28 (+1.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TENX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	771.5M
Net income (ttm)	-57.9M
EPS (ttm)	-$1.40
Shares out	51.1M
Volume	1,966,763
Beta	0.91
Price target	$35.2	+133.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -57.9M
EPS (ttm): -$1.40
Market cap: 771.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All TENX indicators

Market & fundamental data

Available fields

188

Groups with data

Currency

USD

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000034956
Company name	Tenax Therapeutics, Inc.
Country	United States
Country code	US
Cusip	88032L605
Employees	16
Employees Change	10%
Employees Change Percent	166.7
Enterprise value	$652.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US88032L6056
Last refreshed	2026-07-31
Market cap	$771.5M
Market cap category	Small-Cap
Price	$15.1
Price currency	USD
Sector	Healthcare
Sector PE	45.56
Sector PE Fwd	24.38
Sic	2834
Symbol	TENX
Website	https://www.tenaxthera.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.51%
FCF yield	-4.94%
P/B ratio	6.43x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-57.9M
Net Income Growth Years	0%
Profit Per Employee	$-3.6M
ROA	-32.74
Roa5y	-115.8
ROCE	-53.73
ROE	-51.71
Roe5y	-273.8
ROIC	-34.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-57.51%
Cagr15y	-53.72%
Cagr1y	142.91%
Cagr20y	-43.23%
Cagr3y	-16.13%
Cagr5y	-64.82%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$123.2M
Cash	$118.8M
Current Assets	$123.2M
Current Liabilities	$8.5M
Debt	$0
Equity	$114.7M
Liabilities	$8.5M
Long Term Assets	$0
Long Term Liabilities	$0
Net Cash	$118.8M
Net Cash By Market Cap	$15.39
Net Cash Growth	6.56%
Net Debt Equity	$-1.04
Tangible Book Value	$114.7M
Tangible Book Value Per Share	$2.35
WACC	9.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.52
Net Working Capital	$-4.1M
Quick ratio	13.99
Working Capital	$114.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-71.6%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.98%
1Y total return	142.77%
200-day SMA	12.22
3Y total return	-41.02%
50-day SMA	13.52
50-day SMA vs 200-day SMA	50over200
5Y total return	-99.46%
All Time High	29,942,418.4
All Time High Change	-100%
All Time High Date	1993-04-15
All Time Low	2.77
All Time Low Change	445.13%
All Time Low Date	2024-06-21
ATR	1.18
Beta	0.91
Beta1y	0.11
Beta2y	0.61
Ch YTD	23.87
High	15.23
High52	19.4
High52 Date	2026-07-09
High52ch	-22.16%
Low	14.5
Low52	5.78
Low52 Date	2025-08-11
Low52ch	161.25%
Ma50ch	11.69%
Premarket Change Percent	1.28
Premarket Price	$15.01
Premarket Volume	1,967
Price vs 200-day SMA	23.57%
RSI	51.27
RSI Monthly	32.49
RSI Weekly	57.68
Sharpe ratio	1.48x
Sortino ratio	2.76
Total Return	-71.6%
Tr YTD	23.87
Tr15y	-100%
Tr1m	11.85%
Tr1w	3.14%
Tr3m	18.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	4
Analyst Price Target Top	$41
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.37
Operating Income	$-61.6M
Price target	$35.2
Price Target Change	$133
Price Target Change Top	$172

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	26,474,366%
Float Percent	51.82%
Shares Insiders	0.1%
Shares Institutions	46.43%
Shares Out	51,091,766
Shares Qo Q	10.53%
Shares Yo Y	71.6%
Short Float	7.73%
Short Ratio	1.38
Short Shares	4.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-56M
Adjusted OCF	-56,001,000
Average Volume	1,466,104.25x
Bv Per Share	2.35
Ch10y	-99.98
Ch15y	-100
Ch1m	11.85
Ch1w	3.14
Ch1y	142.8
Ch20y	-100
Ch3m	18.15
Ch3y	-41.02
Ch5y	-99.46
Ch6m	12.94
Change	1.89%
Change From Open	1.89
Close	14.82
Days Gap	0
Dollar Volume	29,698,121.3
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-61.6M
EBITDA	$-61.6M
EPS	$-1.4
F Score	1
FCF	$-38.1M
FCF EV Yield	-5.84x
FCF Per Share	$-0.75
Financing CF	45,450,000
Fiscal Year End	December
Founded	1,967
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Date	2024-01-03
Last Split Type	Reverse
Last10k Filing Date	2026-03-10
Ma150	13.48
Ma150ch	12.03%
Ma20	15.89
Ma20ch	-4.97%
Net CF	7,308,000
Next Earnings Date	2026-08-12
Open	14.82
Optionable	Yes
Position In Range	82.19
Post Close	15.1
Postmarket Change Percent	0.18
Postmarket Price	$15.13
Pre Close	14.82
Price Date	2026-07-30
Ptbv Ratio	6.73
Relative Volume	1.36x
Share Based Comp	17,859,000
Tr20y	-100%
Tr6m	12.94%
Us State	North Carolina
Volume	1,966,763

Tenax Therapeutics, Inc. (TENX)

Coverage state: Market snapshot only — no published research

Generate the first TENX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · TENX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TENX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TENX

Frequently asked questions